Amazon.com: The Design and Analysis of Clinical Experiments (Wiley Series in Probability and Statistics) (9780471820475): Joseph L. Fleiss: Books

Sell Back Your Copy
For a $0.50 Gift Card
Trade in
Have one to sell? Sell yours here
The Design and Analysis of Clinical Experiments (Wiley Series in Probability and Statistics)
 
 
Tell the Publisher!
I'd like to read this book on Kindle

Don't have a Kindle? Get your Kindle here, or download a FREE Kindle Reading App.

The Design and Analysis of Clinical Experiments (Wiley Series in Probability and Statistics) [Hardcover]

Joseph L. Fleiss (Author)
4.3 out of 5 stars  See all reviews (3 customer reviews)


Available from these sellers.


Textbook Student FREE Two-Day Shipping for students on millions of items. Learn more

Formats

Amazon Price New from Used from
Hardcover --  
Paperback $122.48  

Book Description

February 20, 1986 0471820474 978-0471820475 1
This reference book on clinical experimentation focuses on principles that are especially useful in the design and analysis of studies on human subjects. It shows how to choose between modern and classical competing designs for a clinical study - such as crossover designs, multicenter studies, and repeated measure experiments - how to carry out each design and analyze the resulting data. The book provides many practical examples, end-of-chapter problems and references, and solutions to each problem. The mathematical bases are given for several design strategies as well as for their analysis. Also provided are tables of critical values, 200 random permutations of the first one hundred integers, and an appendix on programmable methods for determining sample sizes.

Customers Who Bought This Item Also Bought


Editorial Reviews

From the Publisher

This unique reference fills a void in the literature on clinical experimentation by focusing on principles that are especially useful in the design and analysis of studies on human subjects. It shows how to choose between modern and classical competing designs for a clinical study -- such as crossover designs, multicenter studies, and repeated measure experiments -- how to carry out each design and analyze the resulting data. Provides many practical examples, end-of-chapter problems and references, and solutions to each problem. The mathematical bases are given for several design strategies as well as for their analysis. Provides tables of critical values, 200 random permutations of the first one hundred integers, and an appendix on programmable methods for determining sample sizes.

Product Details

  • Hardcover: 432 pages
  • Publisher: Wiley-Interscience; 1 edition (February 20, 1986)
  • Language: English
  • ISBN-10: 0471820474
  • ISBN-13: 978-0471820475
  • Product Dimensions: 9 x 6.4 x 1 inches
  • Shipping Weight: 1.6 pounds
  • Average Customer Review: 4.3 out of 5 stars  See all reviews (3 customer reviews)
  • Amazon Best Sellers Rank: #1,378,624 in Books (See Top 100 in Books)

More About the Author

Discover books, learn about writers, read author blogs, and more.

 

Customer Reviews

3 Reviews
5 star:
 (1)
4 star:
 (2)
3 star:    (0)
2 star:    (0)
1 star:    (0)
 
 
 
 
 
Average Customer Review
4.3 out of 5 stars (3 customer reviews)
 
 
 
 
Share your thoughts with other customers:
Most Helpful Customer Reviews

25 of 25 people found the following review helpful:
4.0 out of 5 stars great reference, now a classic, February 8, 2008
This book was first published in 1986. As Fleiss states in his preface, the intention is to fill a gap in the standard texts on experimental designs by emphasizing and illustrating those that are useful in clinical studies. This book was clearly marketed for the rapidly growing and highly regulated pharmaceutical industry. In addition to the classic experimental designs, Fleiss covers cross-over designs and repeated measure designs that are important in clinical trials. He writes clearly and deals with the important issues in clinical trials including potential biases, blinding, randomized controls, multiple comparisons and repeated measures. The book starts off with a chapter that emphasizes the effect of measurement error and also provides some simple experiments on reliability of measurements.

There is a wealth of methods included, many different designs and various parametric and nonparametric analysis techniques. It is aimed at biostatisticians in the pharmaceutical industry and the medical research field. The book is very much suited for an advanced undergraduate or graduate level course for students majoring in statistics or biostatistics. The level of mathematics is high but not excessively used. Mathematical results on sample size determination are deferred to an appendix.

The Wiley editors choose only successful books to be included in their Classics Library series. The intent of the Classics series is to take popular books by distinguished authors and create a paperback edition that may be more affordable than the hardcovered edition still in print. It is not a revision of the book. This book entered the Classics series in 1999.

It is a great reference source and I plan to consult it a great deal in the future. The only drawback to it that I see is that it is not up to date. The last 15 years has seen many advances in group sequential methods, Bayesian designs and longitudinal data analysis that this text misses. So Fleiss' book is not one stop shopping for a clinical biostatistician but it does offer a lot and presents it eloquently.

With regard to reviewer Izadi's comments on Amazon, I think the appropriate way to ask this question is really to write the author. Since it is here in print for the readers, I will attempt a reply. I think there is a misinterpretation of the terminology. When Fleiss refers to mean logarithms he is not referring to the population means on the log scale but rather the logarithm of the population mean on the original scale. With the latter interpretation equation 3.25 makes perfect sense. It is the former interpretation of the parameters that the reviewers point addresses. The importance in the example is to demonstrate the lack of robustness of t or F tests to non-normal (e.g. lognormal) data and to show that tests and confidence intervals can still be accomplished using the normal theory after the transformation. The key point is that it is the ratio of the parameters that is transformed into differences of the log of the parameters.
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No


5.0 out of 5 stars A must for biostatisticians, December 22, 2000
By A Customer
Amazon Verified Purchase(What's this?)
This is the standard text on this subject. Recommend you have at least a Master's degree in statistics to take full advantage of this book. This book is too technical for non-statisticians, although they may get some useful infomation from the non-statistical discussions.
Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No


1 of 6 people found the following review helpful:
4.0 out of 5 stars A question from the autour, December 10, 2000
By 
Shahrokh Izadi (Tehran University, Public Health School, Iran) - See all my reviews
Dear Sirs I do not know if I can use this part as a tool for contacting the autour or not; however please excuse me if I have not used it properly: I am a student of epidemiology, and presently we are studying the following book: The Design and Analysis of Clinical Experiments; Joseph L. Fleiss; John Wiley & Sons; 1986. But on page 67 it seems that there is some misunderstandings: When we do a log transformation, in fact we are changing (or shifting) the previous distribution to a normal distribution. Without any doubts in this transformation the means of our previous distributions do not transfer to the means of the new distributions! In fact these are the medians of the previous distributions which are transferred to the place of the means of new distributions (of course if we presume that the new distributions are almost perfectly normal) and by finding the confidence interval of the difference of the means of new distributions (lambda1 - lambda2) we are finding the CI of ratio Median1/Median2. In this way it seems reasonable that the formula 3.25 be changed to Median1/ Median2. It would be very kind of you if you help me in this problem!

With best regards Dr. Shahrokh Izadi

Help other customers find the most helpful reviews 
Was this review helpful to you? Yes No

Share your thoughts with other customers: Create your own review
 
 
 
Only search this product's reviews



Inside This Book (learn more)
Browse and search another edition of this book.
First Sentence:
The most elegant design of a clinical study will not overcome the damage caused by unreliable or imprecise measurement. Read the first page
Key Phrases - Capitalized Phrases (CAPs): (learn more)
New York, Source of Variation, Academic Press, Marcel Dekker, National Bureau of Standards, Week Infant, Blackwell Scientific Publications Ltd, Iowa State University Press, Mean Overall, Mean Subject, New Engl, Cambridge University Press, Oxford University Press
New!
Concordance | Text Stats
Browse Sample Pages:
Front Cover | Table of Contents | First Pages | Index | Back Cover | Surprise Me!
Search Inside This Book:


Suggested Tags from Similar Products

 (What's this?)
Be the first one to add a relevant tag (keyword that's strongly related to this product).
 
(5)

Your tags: Add your first tag
 

Sell a Digital Version of This Book in the Kindle Store

If you are a publisher or author and hold the digital rights to a book, you can sell a digital version of it in our Kindle Store. Learn more

Customer Discussions

This product's forum
Discussion Replies Latest Post
No discussions yet

Ask questions, Share opinions, Gain insight
Start a new discussion
Topic:
First post:
Prompts for sign-in
 


Active discussions in related forums
Search Customer Discussions
Search all Amazon discussions
   
Related forums



So You'd Like to...


Create a guide


Look for Similar Items by Category


Look for Similar Items by Subject